In 1997, the U.S. Food and Drug Administration (FDA) Modernization Act reauthorized the Prescription Drug User Fee Act of 1992 and mandated the most wide-ranging reforms in agency practices since 1938.

Provisions include measures to accelerate review of devices, regulate advertising of unapproved uses of approved drugs and devices, and regulated health claims for foods.